Trending...
- THE LEGO GROUP UNVEILS "SAN DIEGO LEGO®-CON" AT SAN DIEGO COMIC-CON 2025
- InventHelp Inventor Develops New Water Dispensing Product for Pets (LOS-325)
- Socket Mobile Announces Second Quarter 2025 Results Release Date and Conference Call
MILPITAS, Calif. , June 18, 2025 ~ Galaxy Therapeutics, a leading medical device company specializing in the treatment of brain aneurysms, has announced the appointment of Dr. Michael Alexander as their new Chief Medical Officer. With over two decades of experience in neurosurgery and clinical research, Dr. Alexander brings a wealth of knowledge and expertise to the company.
In his new role, Dr. Alexander will provide global medical leadership for Galaxy's clinical development programs, including the ongoing Saccular Endovascular Aneurysm Lattice (SEAL™) IT IDE trial and future studies focused on treating complex brain aneurysms with the SEAL device. This newly created position highlights Galaxy's commitment to advancing their innovative technology and bringing it to patients worldwide.
Dr. Alexander is a highly distinguished specialist in the field of neurosurgery, with dual training in cerebrovascular surgery and neurointerventional procedures. He has held various leadership positions at prestigious institutions such as Cedars-Sinai Medical Center in Los Angeles, where he currently serves as Professor and Vice Chair of Neurosurgery, Co-Director of the Comprehensive Stroke Center, Director of the Neurovascular Center, and Staff Physician IV (Neurosurgery). He also served as Team Neurosurgeon for the Los Angeles Rams during their 2016-2017 season.
More on The Californer
Prior to joining Cedars-Sinai, Dr. Alexander spent seven years as an Associate Professor at Duke University Medical Center and completed a fellowship at UCLA Medical Center. Despite his new role at Galaxy Therapeutics, he will continue to serve in his current academic and clinical positions.
Dr. Sam Zaidat, President and CEO of Galaxy Therapeutics, expressed his excitement about having Dr. Alexander join their executive team. He praised Dr. Alexander's extensive experience in clinical trials and his stellar reputation within the neurointerventional community.
"Dr. Alexander's unmatched clinical trial experience, scientific rigor, and stellar reputation in the neurointerventional community make him an ideal Chief Medical Officer," said Dr. Zaidat. "As such, we are honored to welcome him to the executive team and are confident that he will be instrumental in helping us bring our technology to patients worldwide."
Dr. Zaidat also mentioned that Galaxy Therapeutics will continue to expand its clinical and scientific leadership team as they work towards advancing their innovative SEAL device, designed to address the most challenging aneurysm anatomies.
More on The Californer
Throughout his career, Dr. Alexander has participated in over 45 clinical trials and has been continuously funded by the National Institutes of Health (NIH) for the past 18 years. He is a Past President of the Society of NeuroInterventional Surgery (SNIS), co-author of two textbooks, and has published over 160 peer-reviewed articles in the field of neurovascular disease.
Dr. Alexander received his medical degree from Georgetown University School of Medicine and completed fellowships in Neurovascular and Skull Base Surgery at Barrow Neurological Institute and NeuroIntervention at David Geffen School of Medicine at UCLA.
With Dr. Alexander's expertise and leadership, Galaxy Therapeutics is poised to make significant strides in their mission to provide innovative treatments for brain aneurysms. As they continue to grow, they remain committed to expanding their team with top talent in order to bring their technology to patients around the world.
In his new role, Dr. Alexander will provide global medical leadership for Galaxy's clinical development programs, including the ongoing Saccular Endovascular Aneurysm Lattice (SEAL™) IT IDE trial and future studies focused on treating complex brain aneurysms with the SEAL device. This newly created position highlights Galaxy's commitment to advancing their innovative technology and bringing it to patients worldwide.
Dr. Alexander is a highly distinguished specialist in the field of neurosurgery, with dual training in cerebrovascular surgery and neurointerventional procedures. He has held various leadership positions at prestigious institutions such as Cedars-Sinai Medical Center in Los Angeles, where he currently serves as Professor and Vice Chair of Neurosurgery, Co-Director of the Comprehensive Stroke Center, Director of the Neurovascular Center, and Staff Physician IV (Neurosurgery). He also served as Team Neurosurgeon for the Los Angeles Rams during their 2016-2017 season.
More on The Californer
- City of Long Beach Announces Departure of Director of Public Works Eric Lopez
- Vision Pay Launches Revolutionary Shopper Mobile App to Transform Web Commerce
- California: Trump tariff policy continues to cause chaos in American economy
- Free Printable Math Bingo Cards Released for Teachers, Parents, and Students
- Voices for Humanity Sees Hope Spring from the Middle of the World with Catalina Maldonado
Prior to joining Cedars-Sinai, Dr. Alexander spent seven years as an Associate Professor at Duke University Medical Center and completed a fellowship at UCLA Medical Center. Despite his new role at Galaxy Therapeutics, he will continue to serve in his current academic and clinical positions.
Dr. Sam Zaidat, President and CEO of Galaxy Therapeutics, expressed his excitement about having Dr. Alexander join their executive team. He praised Dr. Alexander's extensive experience in clinical trials and his stellar reputation within the neurointerventional community.
"Dr. Alexander's unmatched clinical trial experience, scientific rigor, and stellar reputation in the neurointerventional community make him an ideal Chief Medical Officer," said Dr. Zaidat. "As such, we are honored to welcome him to the executive team and are confident that he will be instrumental in helping us bring our technology to patients worldwide."
Dr. Zaidat also mentioned that Galaxy Therapeutics will continue to expand its clinical and scientific leadership team as they work towards advancing their innovative SEAL device, designed to address the most challenging aneurysm anatomies.
More on The Californer
- Tsunami Advisory Lifted for Long Beach, Other Southern California Coastal Cities
- Japanese Tradition Meets Hollywood Glitz
- FACTOR Acting School Announces Major Sale on "The Fundamentals of Acting" Course
- Meemzy Magic Brings the Gift of Time and Connection to the Back-to-School Season
- Tek Talk Show Premieres July 31st: The Future of TV, AITV's Vision, Founders & the Journey Ahead
Throughout his career, Dr. Alexander has participated in over 45 clinical trials and has been continuously funded by the National Institutes of Health (NIH) for the past 18 years. He is a Past President of the Society of NeuroInterventional Surgery (SNIS), co-author of two textbooks, and has published over 160 peer-reviewed articles in the field of neurovascular disease.
Dr. Alexander received his medical degree from Georgetown University School of Medicine and completed fellowships in Neurovascular and Skull Base Surgery at Barrow Neurological Institute and NeuroIntervention at David Geffen School of Medicine at UCLA.
With Dr. Alexander's expertise and leadership, Galaxy Therapeutics is poised to make significant strides in their mission to provide innovative treatments for brain aneurysms. As they continue to grow, they remain committed to expanding their team with top talent in order to bring their technology to patients around the world.
Filed Under: Business
0 Comments
Latest on The Californer
- California: Governor Newsom announces appointments 7.29.25
- California: Governor Newsom signs legislation 7.29.25
- Meet a Scientologist Designs for Life with Brad Napier
- KIA BRINGS THE FUTURE TO THE HISTORIC KIA FORUM WITH THE "KIA CONNECTED HOME"
- California pre-deploys resources in Plumas, Nevada, and Sierra counties ahead of critical fire weather conditions
- Artbound: "The Cheech" Awarded Two 2025 LA Area EMMY Awards — Honored in ARTS & MUSIC COMPOSITION
- California: Governor Newsom issues emergency proclamation for storm-impacted counties
- Rising Conservative Star Jordan Brace Emerges as Influential Political Voice with Elite Washington Connections
- Conservative Latinos for PA Shaping the Future of Hispanic Community, Guest State Treasurer Stacy Garrity
- California Patriots Organize Newsom Redial Rally 2025 At State Capitol To Address State Leadership Crisis
- White Glove Restoration Earns CIRSX Certification for Medically Important Mold Remediation
- California: Governor Newsom responds to latest Trump sledgehammer to clean air protections
- Long Beach Parks, Recreation and Marine to Offer a Variety of Recreation Classes This Fall
- Chasing Creative Plants Roots in Palm Coast, Builds Marketing Systems for Modern B2B Brands
- Promises kept — new data shows 22,000 arrests and $150 million in recovered stolen goods across California
- InventHelp Inventor Develops Modified Rear Lighting System for Vehicles (SNF-457)
- David M. White, DDS Celebrates 500 Five-Star Reviews in Reno
- Jamal Hill Named Aqua by Delfino Brand Ambassador in LA28 Swim Equity Campaign
- TopJobsToday Tracks Fresh FAANG+ Job Postings Every Day
- Pension Resource Institute, LLC Named a Finalist in the Wealth Management 2025 Industry Awards